Cargando…

Challenges in the development of clinical trials for major depressive disorder: lessons learned from trials in minor depression

This paper reviews some of the challenges faced by individuals who design and implement clinical trials of potential antidepressant medications. Particular emphasis is placed on questioning the validity of some of the theoretical assumptions that form the underpinnings of most conventional trials. W...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rapaport, Mark H., Maddux, Rachel E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Les Laboratoires Servier 2002
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181702/ https://www.ncbi.nlm.nih.gov/pubmed/22034443

Ejemplares similares

Mood and Global Symptom Changes among Psychotherapy Clients with Depressive Personality
por: Maddux, Rachel E., et al.
Publicado: (2012)

Double-Blinding and Bias in Medication and Cognitive-Behavioral Therapy Trials for Major Depressive Disorder
por: Berger, Douglas
Publicado: (2016)

The importance of assessing personality traits and disorders in clinical trials of major depressive disorder
por: Husain, M. Ishrat, et al.
Publicado: (2020)

Audio-digital recordings for surveillance in clinical trials of major depressive disorder
por: Targum, Steven D., et al.
Publicado: (2019)

Lessons learned from recruiting into a longitudinal remote measurement study in major depressive disorder
por: Oetzmann, Carolin, et al.
Publicado: (2022)

Comorbidity between post-traumatic stress disorder and major depressive disorder: alternative explanations and treatment considerations
por: Flory, Janine D., et al.
Publicado: (2015)

Epilogue: Lessons from the CONVERGE study of major depressive disorder in China
por: Flint, Jonathan, et al.
Publicado: (2012)

A continuum of genetic liability for minor and major depression
por: Corfield, E C, et al.
Publicado: (2017)

Major depressive disorder: Validated treatments and future challenges
por: Karrouri, Rabie, et al.
Publicado: (2021)

Clinical Phenotypes Characterization in Pharmacogenetics Testing Trials for Major Depressive Disorder Treatment
por: Minelli, A.
Publicado: (2022)

Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned
por: Wray, N R, et al.
Publicado: (2012)

Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorder
por: Leuchter, Andrew F., et al.
Publicado: (2014)

Sex Differences in Intergenerational Transfer Risk of Major Depressive Disorder
por: Fang, Guoxiang, et al.
Publicado: (2019)

Preventive Effect of Liothyronine on Electroconvulsive Therapy-Induced Memory Deficit in Patients with Major Depressive Disorder: A Double-Blind Controlled Clinical Trial
por: Mohagheghi, Arash, et al.
Publicado: (2015)

Detection of Minor and Major Depression through Voice as a Biomarker Using Machine Learning
por: Shin, Daun, et al.
Publicado: (2021)

Collaborative care for depression and anxiety disorders: results and lessons learned from the Danish cluster-randomized Collabri trials
por: Curth, Nadja Kehler, et al.
Publicado: (2020)

Association between AKT1 gene polymorphisms and depressive symptoms in the Chinese Han population with major depressive disorder★
por: Yang, Chunxia, et al.
Publicado: (2012)

A Comparative clinical trial on the role of Panchakarma therapy and Unmada Gajankusha Rasa in the cases of major depressive disorder vis-à-vis kaphaja Unmada
por: Dubey, Sarvesh, et al.
Publicado: (2010)

Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder
por: Papakostas, George I., et al.
Publicado: (2008)

Patient-reported outcomes before and after treatment of major depressive disorder
por: IsHak, Waguih William, et al.
Publicado: (2014)

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial
por: Davis, Alan K., et al.
Publicado: (2020)

Progress and challenges in research of the mechanisms of anhedonia in major depressive disorder
por: Su, Yun-Ai, et al.
Publicado: (2022)

How can we successfully recruit depressed people? Lessons learned in recruiting depressed participants to a multi-site trial of a brief depression intervention (the ‘CLASSIC’ trial)
por: Brown, June S. L., et al.
Publicado: (2019)

Genetic evidence suggests posttraumatic stress disorder as a subtype of major depressive disorder
por: Zhang, Fuquan, et al.
Publicado: (2022)

Effectiveness of trauma-focused treatment for adolescents with major depressive disorder
por: Paauw, Corine, et al.
Publicado: (2019)

Major Depressive Episode and Generalized Anxiety Disorder Among Sexual Minority Adults in the United States
por: Exten, Cara, et al.
Publicado: (2020)

Pharmacological Treatment of Major Depressive Disorder in Adolescents
por: Farley, Rachel L.
Publicado: (2005)

Randomized controlled trials of serotonin-norepinephrine reuptake inhibitor in treating major depressive disorder in children and adolescents: a meta-analysis of efficacy and acceptability
por: Xu, Y., et al.
Publicado: (2016)

Suicidal Risks in Reports of Long-Term Treatment Trials for Major Depressive Disorder
por: Baldessarini, Ross J., et al.
Publicado: (2015)

Are subsyndromal symptomatic depression and major depressive disorder distinct disorders?
por: Yi, Zhenghui, et al.
Publicado: (2012)

The effects of combined sertraline and aspirin therapy on depression severity among patients with major depressive disorder: A randomized clinical trial
por: Sepehrmanesh, Zahra, et al.
Publicado: (2017)

A Meta-Analysis Comparing Open-Label versus Placebo-Controlled Clinical Trials for Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: Lessons and Promises
por: Pae, Chi-Un, et al.
Publicado: (2014)

Near-Infrared Transcranial Radiation for Major Depressive Disorder: Proof of Concept Study
por: Cassano, Paolo, et al.
Publicado: (2015)

The Effect of Eye Movement Desensitization and Reprocessing (EMDR) on the severity of suicidal thoughts in patients with major depressive disorder: a randomized controlled trial
por: Fereidouni, Zhila, et al.
Publicado: (2019)

The PRESIDE (PhaRmacogEnomicS In DEpression) Trial: a double-blind randomised controlled trial of pharmacogenomic-informed prescribing of antidepressants on depression outcomes in patients with major depressive disorder in primary care
por: Saya, Sibel, et al.
Publicado: (2023)

Design and methods for a randomized clinical trial treating comorbid obesity and major depressive disorder
por: Schneider, Kristin L, et al.
Publicado: (2008)

Short- and Long-Term Antidepressant Clinical Trials for Major Depressive Disorder in Youth: Findings and Concerns
por: Safer, Daniel J., et al.
Publicado: (2019)

Possible association of Firmicutes in the gut microbiota of patients with major depressive disorder
por: Huang, Yichen, et al.
Publicado: (2018)

Challenges in the diagnosis and treatment of depression in autism spectrum disorders across the lifespan
por: Chandrasekhar, Tara, et al.
Publicado: (2015)

Comparison of post-COVID depression and major depressive disorder
por: Perlis, Roy H., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g3klt6cb6gv343h6ojlkge86ks